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The roles that human immunodeficiency virus (HIV) and Epstein–Barr virus (EBV) play in the genesis of aquired immune
deficiency syndrome (AIDS)-related lymphomas are not understood. A human B cell line (B-HIV), developed to study
AIDS-related lymphomagenesis, contains EBV and HIV genomes and is malignantly transformed. This line was produced by
exposing B cells from an EBV-seropositive donor to HIV. To investigate the number of independent transformation events that
took place at the time of HIV infection, we sought to determine how many transformed lineages are present in this cell line.
B-HIV was found to have multiple different sites of HIV integration ($25) as determined by fluorescence in situ hybridization.
As a control, we analyzed a clonal cell line of HIV-infected human T cells, 8E5, and found HIV sequences located exclusively
at band q22 in chromosome 13. We conclude that B-HIV is polyclonal, and viral sequences are located at multiple variable
chromosomal sites in different B-HIV cells. © 1998 Academic Press
INTRODUCTION
About 20% of individuals infected with HIV are ex-
pected to develop a B cell lymphoma (Levine, 1992; Gail
et al., 1991). Both human immunodeficiency virus (HIV)
and Epstein–Barr virus (EBV) have been found in some
tumors (Hamilton et al., 1991; Pedersen et al., 1991),
suggesting that one or both viruses may have contrib-
uted to malignant transformation. EBV is known to im-
mortalize B cells in cell culture and to contribute to
oncogenesis (e.g., Burkitt’s lymphoma and nasopharyn-
geal carcinoma) (for review, see Rickinson and Kieff,
1996). Although HIV is not generally considered to be
oncogenic (Gaidano and Dalla-Favera, 1992; Groopman
et al., 1986; Pelicci et al., 1984), some evidence for its
oncogenic potential has been reported in a few cases of
AIDS-NHL (Ng and McGrath, 1998).
To investigate the roles of HIV and EBV in lym-
phomagenesis, Laurence and Astrin (1991) developed
two cell lines by infecting with HIV or with EBV nonim-
mortalized peripheral B cells from a healthy HIV-seroneg-
ative, EBV-seropositive individual. One cell line, termed
B-HIV, resulted after infection with HIV and expressed
EBV-associated antigens. The other, termed B-EBV, re-
sulted after infection with EBV. Malignant transformation
occurred in the EBV- and HIV-infected cells but not in the
EBV-infected control. B-HIV has the properties of a ma-
lignantly transformed B cell, including overexpression of
the c-MYC proto-oncogene, as well as the ability to grow
in 1% serum, clone in soft agar, and form malignant
tumors in SCID mice. The genesis and properties of
B-HIV and B-EBV are described more fully in Laurence
and Astrin (1991), Astrin and Laurence (1992), and Lau-
rence et al. (1993). Because HIV does not replicate in
these cultures after the initial infection, eliminating cell-
to-cell spread, these data suggested that HIV infection
induced transformation. The alternative explanation, that
transformation was spontaneous, is ruled out by the fact
that no transformation occurred in the control, whereas
multiple events must have occurred in the HIV-infected
culture at precisely the same time.
To obtain evidence for the total number of independent
transformation events that must have occurred at the
time of HIV infection, we asked how many transformed
lineages were present, using HIV DNA as a probe for
fluorescence in situ hybridization (FISH) analysis. The
results indicate that most cells contained only a single
integration. Some evidence for the same integration site
in different metaphases was obtained by FISH; nonethe-
less, B-HIV was polyclonal, originating from $25 inde-
pendent events resulting from HIV infection.
RESULTS
In a first set of experiments, we hybridized metaphase
chromosome preparations from B-HIV cells with biotin-
labeled cloned DNA representing the 59 half of the HIV
genome (nick-translated pBH 5.2). Hybridized probe was
detected with avidin-FITC, and only those metaphases in
which both sister chromatids labeled at the same loca-
tion were scored. Typically, only a single such hybridiza-
tion site, indicative of a viral integration, was observed in
a given metaphase. The top left panel of Fig. 1 (A–C)
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show some of these data, with HIV located at chromo-
some bands 20p11 (A), 2q32 (B), and 8q22 (C). Using this
probe, we identified HIV sequences at 14 different loca-
tions.
As a control, we performed FISH analysis of a clonal
line of HIV-infected T cells, 8E5 (Folks et al., 1986). Using
the same probe as that used above for B-HIV, we found
that HIV sequences were located exclusively at 13q22
(Fig. 1H). As an alternative method for the localization of
HIV sequences in 8E5 cells, we isolated the cellular DNA
FIG. 1. Fluorescence in situ hybridization of B-HIV (A–G) and 8E5 (H and I) cells with labeled HIV DNA probes. Arrows indicate hybridization signals.
The upper panels (A–C and H) show hybridization with a biotin-labeled pBH 5.2 probe (representing a 59 5.2-kb segment of the HIV genome) visualized
with FITC conjugated to avidin. The lower panels (D–G and I) show hybridization with two HIV DNA probes; one probe is the 59 half of the HIV genome
described above and visualized with Texas red conjugated to avidin (red fluorescence), and the other is the 39 half (3.5-kb, pBH 8.1) labeled with
digoxigenin and visualized with FITC conjugated to anti-digoxigenin antibodies (green fluorescence). The inset in panel I represents chromosome 13
of three different 8E5 metaphases; all show hybridization to 13q22. Chromosomes were counterstained with DAPI or propidium iodide (A–C).
Overlapping green and red signals appear as white-yellow (D–G and I).
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sequence adjacent to the integrated viral DNA and de-
termined its chromosomal residence using a monochro-
mosomal somatic cell hybrid panel of 24 hybrid cell line
DNAs (Bios Laboratories), each carrying a single human
chromosome. The cellular DNA sequence adjacent to
the viral DNA was obtained from an 8E5–HIV DNA junc-
tion. The junction was isolated by a ligation-mediated
PCR method (Quivy and Becker, 1993) as described un-
der Materials and Methods. The DNA sequence adjacent
to the viral DNA was determined, and primers selected
from this sequence were used for PCR with each of the
24 monochromosomal somatic cell hybrid DNAs. The
expected 71-bp band was detected only with DNA from
human chromosome 13. This result confirms that 8E5
cells harbor HIV in chromosome 13.
In a second set of experiments, cloned probe repre-
senting one half of the HIV genome (pBH 5.2) was la-
beled with biotin, and the other half of the genome (pBH
8.1) was labeled with digoxigenin. The digoxigenin-la-
beled probe was detected with FITC labeled anti-digoxi-
genin antibodies (green fluorescence) and the biotinyl-
ated probe with avidin-Texas red (red fluorescence). Only
metaphases exhibiting colocalization of the red and
green signals were scored. Results for B-HIV are shown
in Figs. 1D–1G. The population of B-HIV cells contains
multiple different sites of HIV integration. In the four
examples shown, from four different cells, HIV se-
quences are located at 12q13 (D), 2p21 (E), 5q13–14 (F),
and 1p22–31 (G). Use of the same pair of probes on
multiple metaphases of B-HIV resulted in the identifica-
tion of viral sequences at 25 different chromosomal lo-
cations, four of which had already been seen in the first
experiment. Four other sites were identified more than
once in the second FISH experiment. Again, HIV se-
quences in the 8E5 control were located only at chromo-
some 13q22 (Fig. 1I).
Chromosomal locations that we have been able to
identify in both sets of experiments are shown in Table 1.
Locations that were seen more than once in bold. The
largest chromosomes, 1–4, accounted for more than half
(64%) of the identified integrations. This is to be expected
if we account for target size. The fact that 8 of a total of
35 sites have been identified more than once implies that
cells containing these integration sites are in greater
abundance.
DISCUSSION
The conclusion to be made from these experiments is
that HIV sequences are located at multiple variable sites
in different B-HIV cells. Most, if not all cells, contain a
single integration event. We did not observe a single
metaphase with two (or more) integration events. Fur-
thermore, the experiments showing colocalization of 59
and 39 HIV sequences provide evidence that some of the
sites detected contain the whole HIV virus, not just part
of it. In addition, the data suggest that integration may
not be entirely random because the same integration
sites are observed quite frequently (8 of 35 sites have
been identified more than once). Especially striking in
this respect is the fact that HIV was found integrated at
the same chromosomal site in both B-HIV and 8E5 cells
(i.e., 13q22). It is also possible that some cells have a
growth advantage and thus appear more frequently than
others.
If malignant transformation of B lymphocytes occurs in
vitro at a demonstrable frequency, it may also occur in
HIV-infected individuals, thereby generating a subset of
lymphomas with a viral etiology. The etiology of AIDS-
related non-Hodgkin’s lymphoma (NHL) appears to be
complex. Knowles (1996) indicated that more than one
pathogenetic mechanism is operational in the develop-
ment of AIDS-related NHL. One mechanism of retroviral
transformation in animal systems is insertional mutagen-
esis, in which integration of the retroviral LTR transcrip-
tionally activates an adjacent cellular protooncogene.
The original evidence for this mechanism was provided
in a study of ALV-induced bursal lymphomas in the
chicken (Hayward et al., 1981). It was found that onco-
genesis results from activation of the cellular myc gene
by ’’promoter insertion.’’ Because insertion of provirus
adjacent to a particular cellular gene is a rare event,
tumors induced by insertional mutagenesis are clonal. A
number of investigators have used Southern blots to
probe the DNA of AIDS lymphomas for the presence of
HIV sequences and have failed to document the pres-
ence of clonally integrated HIV provirus. Thus there cur-
rently is no evidence for insertional mutagenesis with
HIV in B cells. However, in a few cases, HIV was found
clonally integrated near the c-fes gene of macrophages
present in some AIDS-related lymphomas (Ng and
McGrath, 1998).
TABLE 1
Chromosomal Locations for HIV Provirus in B-hiv Cells
1p32, 1p22–31, 1p13, 1q21, 1q32, 1q42, 1q43
2p24, 2p22, 2p21, 2q11–12, 2q13, 2q33, 2q37
3p25, 3p23, 3p21, 3q23
4p14, 4q12, 4q21, 4q27, 4q31
5q13–14
6p21
8q22
10q22
12q13
13q14, 13q22
15q22
16q22
17q21
20p11
21p11
Note. Chromosomal locations seen more than once in both sets of
experiments are shown here in bold type.
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Although the failure to detect HIV sequences in lym-
phoma DNA has led to the conclusion that these tumors
generally do not contain HIV-1, reevaluation of this con-
clusion is warranted in light of the possibility that tumors
containing HIV may be polyclonal. Tumors induced by
the acute transforming viruses are the result of expres-
sion of a viral oncogene in infected cells, and these
tumors are polyclonal. Indeed, based on the B-HIV
model, one might expect to find AIDS B lymphomas that
are polyclonal and contain both EBV and HIV sequences.
If, in fact, tumors containing HIV are polyclonal and
contain multiple different proviruses and multiple differ-
ent insertion sites, Southern blots are not the method of
choice for detection because these experiments probe
for the junctions between viral and cellular sequences. In
a polyclonal tumor with a large number of junctions, the
best result that could be expected would be a smear of
hybridization. However, because the proviruses in the
tumors are likely to be diverged from the sequence of
laboratory virus, a tumor-specific probe, as opposed to
laboratory virus probe, is necessary to maximize hybrid-
ization efficiency and obtain a result. The design of
experiments in the current literature is inadequate for the
detection of multiple different proviruses with diverged
sequences integrated into multiple different sites in tu-
mor DNA. We recently obtained evidence for a subset of
AIDS-related non-Hodgkin’s B cell lymphomas that have
a high load of HIV, contain EBV, and are polyclonal
(Rodriguez-Alfageme et al., manuscript in preparation).
The fact that these tumors, as well as the B-HIV cells, are
polyclonal is important because it indicates the putative
HIV transforming activity is independent of the site of
integration.
The data presented here are consistent with, but do
not prove, a role for an HIV gene product in the genesis
of B-HIV. The identity of this gene and the mechanism of
transformation are not known, but several scenarios are
possible, including Tat activation of EBV genes, cellular
oncogenes (e.g., myc), and/or growth-promoting cyto-
kines. A role for EBV genes must also be considered
because both B-HIV and clinical lymphomas with a high
load of HIV harbor EBV provirus (Laurence and Astrin,
1991; Astrin and Laurence, 1992; Laurence et al., 1993;
Rodriguez-Alfageme et al., manuscript in preparation).
We propose that malignant transformation of B cells may
result from the action of an HIV gene product coupled
with the action of one or more EBV gene products. The
validation of this model, as well as the identification of
these gene products and their relevance to lym-
phomagenesis in vivo, awaits further study.
MATERIALS AND METHODS
The B-HIV cell line was derived from human peripheral
blood B cells from a healthy donor. Its preparation and
culture have been described in Laurence and Astrin
(1991). The 8E5, a human T cell-derived cell line used as
a control in our experiments, contains one copy per cell
of the HIV-1 genome and is described in Folks et al.
(1986) and Gendelman et al. (1992). Preparation of meta-
phase chromosomes from B-HIV and 8E5 cells was per-
formed as described by Rodriguez-Alfageme et al. (1992).
Briefly, slides with metaphase chromosomes were baked
at 60°C overnight and treated with RNase A for 1 h at
37°C. DNA was denatured in 70% formamide at 70°C for
2 min followed by rapid cooling and dehydration in an
ethanol series. Probes were prepared as follows: two
plasmid DNA segments derived from HIV-1, pBH 5.2 (5.5
kb) and pBH 8.1 (3.5 kb), representing nonoverlapping 59
and 39 ends of the HIV genome, respectively (Hahn et al.,
1984; Ratner et al., 1985), were labeled with either biotin-
14-dATP, biotin-11-dUTP, or digoxigenin-dUTP by nick
translation and purified with NucTrap push columns
(Stratagene). The appropriate mix of probes was com-
bined with human Cot 1 DNA (Boehringer-Mannheim),
precipitated with ethanol, and dissolved in Hybrisol VII
(Oncor). Probes were denatured at 75°C for 10 min,
rapidly cooled on ice, and hybridized to denatured (5 min
at 70°C) chromosome preparations at 37°C for 16 h.
Posthybridization washings were in 2 3 SSPE (pH 7.4) at
72°C for 5 min. Hybridization sites were detected with
FITC, rhodamine, or Texas red conjugated to avidin or to
anti-digoxigenin antibodies. Chromosome preparations
were stained with propidium iodide or diamidino-2-phe-
nylindole (DAPI) containing 1,4-diazabicyclo-octane (an
antifading agent). Epifluorescence microscopy and mi-
crophotography were performed as described previously
(Rodriguez-Alfageme et al., 1992). Some images were
captured with a cooled charged coupled device (Photo-
metrics) operated by a Macintosh computer workstation
(Bell et al., 1995). Digitized images of DAPI staining and
hybridization signals were captured separately, pseudo-
colored, and merged using Oncor version 1.6 software.
The 8E5–HIV DNA junction was isolated as follows:
8E5 DNA was digested with HindIII, denatured, and
annealed to primer 59-GGCCCTGGTGTGTAGTTCTGC-
CAATCA-39 (located in the LTR region of HIV near the
59 end). After primer extension with Vent exo(2) (New
England Biolabs), products were ligated with T4 ligase
(New England Biolabs) to linkers (59-GCGGTGACC-
CGGGAGATCTGAATTC-39/59-GAATTCAGATC-39). The
products of these reactions were used in a PCR assay
with primer 59-CTTGTCTTCGTTGGGAGTGAATTAGC-
CC-39 (nested to the primer above and near the 59 end
of the LTR) and primer 59-GCGGTGACCCGGGAGATCT-
GAATTC-3 (present in the linker). This PCR yielded a
single band (130 bp); its DNA was subsequently TA
cloned (InVitrogen) and sequenced (dye terminator
method, Applied Biosystems). The sequence obtained
is as follows: 59-gcggtgacccgggagatctgaattcAGCTTT-
GGCTGTTCGGTTTTCTTGCCCTCTCTTTAATTACAA-
TTTTCAAGCAAATACTTGTGAGCTCAAGGCCTCTTTC-
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tggaagggct aattcactcccaacgaagacaag-39 (GenBank
Accession No. AF096271). The 8E5 cellular DNA is
indicated as bold text, the beginning of the long ter-
minal repeat follows this sequence, and the linker
sequence precedes it. As expected, the HindIII site
follows the linker sequence. These results show that
this DNA is in fact the viral–cellular junction. To local-
ize the chromosomal site of residence of the cell DNA
adjacent to the virus, primers derived from this DNA
(59-TTTTGGCTGTTCGGTTTTCT-39 and 59-GGCCTT-
GAGCTCACAAGTAT-39) were used for PCR with the 24
monochromosomal somatic cell hybrid DNAs (Bios
Laboratories), each carrying the DNA from a single
human chromosome. DNA from chromosome 13 was
the only one of the 24 DNAs that yielded the expected
71-bp band.
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